DIAGNOSTICS
I
iPOCT first to gain UK accreditation for point-of-care testing ndependent Point of Care
Service Delivery: Clinical & Quality Governance
Testing Services (iPOCT) has become the first organisation to be granted UK
accreditation for point-of-care testing. This accreditation gives confidence in the competence of iPOCT’s innovative, customer- focused testing service and may ultimately lead to improved clinical care for patients.
iPOCT, a trading division of Unilabs Ltd, was granted accreditation in October 2009 to ISO 15189 and 22870 by UKAS following a robust assessment of its POCT services. One feature of ISO 22870 is that providers of point-of-care testing should be involved in clinical governance, something that is addressed during assessments
Point-of-care testing enables patient samples to be analysed at the time of their clinic visit
Organisation Group CEC POCT Board Escalation procedures for non closure of non conformities
Testing Location
iPOCT Operations iPOCT QMT UKAS Unilabs Risk Register
thus offering better access and providing faster results for immediate clinical decision making. Increased community- based testing could limit the number of visits a patient has to make to hospitals and clinics and may even reduce the number of people admitted to hospital. The model of service delivery is hub and spoke where the hub is iPOCT and the spokes are the
various customer site locations where the testing takes place. All spoke sites benefit from a single contact point for all queries relating to POCT. This includes general enquiries, technical help, clinical advice and placing orders for all POCT related consumables. In essence it’s a ‘one stop shop.’ One of the most innovative aspects of iPOCT’s approach is the way it interacts
Testing Location
with its customers. The model incorporates processes for: ensuring ‘appropriate testing’ that will bring benefits to the clinical pathway; consideration of cost efficiencies in terms of the entire patient pathway and ability of the health care organisation to adjust clinical processes to make the best use of POCT; full end to end connectivity to capture all test data with 24 hour monitoring of connections.; integration of test results into information systems; organisation of staff who undertake testing, including training, competence assessment and ongoing monitoring; robust framework for clinical governance.
iPOCT is independent of any IVD supplier and as such selects and validates analysers for use in alternative clinical settings to be fit for purpose.
24 nhe
Jul/Aug 10
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100